Allstate (ALL) Price Target Raised After Major Q3 2025 Earnings Beat

The Allstate Corporation (NYSE:ALL) ranks among the Best Low Volatility Investments in December 2025. On November 26, Roth/MKM increased its price target for The Allstate Corporation (NYSE:ALL) from $230 to $240, while continuing to rate the insurance company’s shares as a Buy. According to the firm, Allstate’s impressive third quarter 2025 performance, which greatly exceeded expert forecasts, is what prompted the rise.

The insurer’s adjusted net income per share came in sat $11.17, which surpassed the $7.52 consensus projection. Furthermore, Allstate’s revenue exceeded the estimated $15.69 billion to hit the $17.3 billion mark. Additionally, The Allstate Corporation (NYSE:ALL) demonstrated growth in its customer base, as evidenced by the 1.3% increase in personal auto policies-in-force during the quarter, a statistic that had already been disclosed.

Roth/MKM credited the The Allstate Corporation (NYSE:ALL)’s earnings beat mostly to stronger underlying performance and positive loss reserve growth in personal car injury and physical damage coverages.

The Allstate Corporation (NYSE:ALL) offers a variety of insurance services and products, such as protection, health, and property and casualty insurance. In addition, the company offers consumer protection plans, roadside assistance, and analytics solutions.

While we acknowledge the potential of ALL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This article is originally published at Insider Monkey.